» Articles » PMID: 26925431

Clinical Features of Spontaneous Partial Healing During Mycobacterium Ulcerans Infection

Overview
Date 2016 Mar 1
PMID 26925431
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background.  Buruli ulcer, caused by Mycobacterium ulcerans, is a necrotizing skin disease leading to extensive cutaneous and subcutaneous destruction and functional limitations. Spontaneous healing in the absence of medical treatment occurs in rare cases, but this has not been well described in the literature. Methods.  In a retrospective case study in an area of Benin where this disease is highly endemic, we selected 26 Buruli ulcer patients presenting features of spontaneous healing from a cohort of 545 Buruli ulcer patients treated between 2010 and 2013. Results.  The 26 patients studied had a median age of 13.5 years and were predominantly male (1.4:1). Three groups of patients were defined on the basis of their spontaneous healing characteristics. The first group (12 patients) consisted of patients with an ulcer of more than 1 year's duration showing signs of healing. The second (13 patients) group contained patients with an active Buruli ulcer lesion some distance away from a first lesion that had healed spontaneously. Finally, the third group contained a single patient displaying complete healing of lesions from a nodule, without treatment and with no relapse. Conclusions.  We defined several features of spontaneous healing in Buruli ulcer patients and highlighted the difficulties associated with diagnosis and medical management. Delays in consultation contributed to the high proportion of patients with permanent sequelae and a risk of squamous cell carcinoma. Early detection and antibiotic treatment are the best ways to reduce impairments.

Citing Articles

A rapid and simple MALDI-TOF MS lipid profiling method for differentiating from .

Komine T, Fukano H, Yoshida M, Miyamoto Y, Nakaya M, Fujinaga A J Clin Microbiol. 2025; 63(3):e0140024.

PMID: 39868779 PMC: 11898672. DOI: 10.1128/jcm.01400-24.


Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles.

Bernard Q, Goumeidane M, Chaumond E, Robbe-Saule M, Boucaud Y, Esnault L PLoS Pathog. 2023; 19(7):e1011479.

PMID: 37428812 PMC: 10358927. DOI: 10.1371/journal.ppat.1011479.


Membrane Active Immunomodulator As a Novel Therapy for an Infectious Bacterial Disease, Buruli Ulcer.

Izbicka E, Streeper R, Louden C In Vivo. 2022; 36(6):2615-2629.

PMID: 36309402 PMC: 9677771. DOI: 10.21873/invivo.12996.


Transcriptional adaptation of in an original mouse model: New insights into the regulation of mycolactone.

Robbe-Saule M, Foulon M, Poncin I, Esnault L, Varet H, Legendre R Virulence. 2021; 12(1):1438-1451.

PMID: 34107844 PMC: 8204960. DOI: 10.1080/21505594.2021.1929749.


High antibody titres induced by protein subunit vaccines using antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice.

Mangas K, Tobias N, Marion E, Babonneau J, Marsollier L, Porter J PeerJ. 2020; 8:e9659.

PMID: 32844063 PMC: 7416718. DOI: 10.7717/peerj.9659.


References
1.
Pommelet V, Vincent Q, Ardant M, Adeye A, Tanase A, Tondeur L . Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection. Clin Infect Dis. 2014; 59(9):1256-64. DOI: 10.1093/cid/ciu584. View

2.
Browne S . Self-healing leprosy: report on 2749 patients. Lepr Rev. 1974; 45(2):104-11. DOI: 10.5935/0305-7518.19740012. View

3.
Vincent Q, Ardant M, Adeye A, Goundote A, Saint-Andre J, Cottin J . Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. Lancet Glob Health. 2014; 2(7):e422-30. DOI: 10.1016/S2214-109X(14)70223-2. View

4.
Vincent Q, Ardant M, Marsollier L, Chauty A, Alcais A . HIV infection and Buruli ulcer in Africa. Lancet Infect Dis. 2014; 14(9):796-7. DOI: 10.1016/S1473-3099(14)70882-5. View

5.
Johnson R, Ifebe D, Hans-Moevi A, Kestens L, Houessou R, Guedenon A . Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study. AIDS. 2002; 16(12):1704-5. DOI: 10.1097/00002030-200208160-00027. View